Spot-fixing scandal: BCCI chief's son-in-law arrested
NEW DELHI (Reuters) - Mumbai Police apprehended Gurunath Meiyappan, a key official of the Indian Premier League's (IPL) Chennai franchise, late on Friday in connection with a spot-fixing scandal that has also led to the arrest of three cricketers.
Former test bowler Shanthakumaran Sreesanth and two other local cricketers were arrested last week on suspicion of taking money to concede a fixed number of runs and police have intensified investigations to discover the extent of the scandal.
Meiyappan, son-in-law of Indian cricket board (BCCI) president N Srinivasan, was arrested after being quizzed for hours by Mumbai Police probing illegal betting on the Twenty20 league.
"We have gone through questioning him in detail and after due deliberation, we've come to the conclusion that there is evidence of his involvement in this offence that we are investigating..." joint commissioner of Mumbai Police Himanshu Roy told reporters on Friday.
"... therefore he has been placed under arrest and will be produced in court within 24 hours as per the law."
Local media claimed Meiyappan was chief executive of the Chennai Super Kings but India Cements, the company that owns the franchise, said he was merely a member of team management.
Sreesanth has denied any role in spot-fixing.
India's film industry also got mixed up in the controversy when Mumbai Police arrested Bollywood actor Vindu Dara Singh on Tuesday for alleged links to a bookmaker.
The International Cricket Council (ICC) withdrew elite panel umpire Asad Rauf of Pakistan, who officiates in IPL, from next month's Champions Trophy on Thursday following media reports he was under investigation by Mumbai Police.
Legal sports betting in India is confined to horse racing.
(Reporting by Amlan Chakraborty; Editing by John O'Brien)
- Tweet this
- Share this
- Digg this
Indian drugmakers are fleeing a regulatory morass at home and moving some research and development to Europe and the United States as try to boost margins by producing high-value drugs. India's $15 billion a year pharma industry is already reeling from a string of drug recalls and quality control issues which have called into question the regulator's oversight. Full Article
Adani buys Australia coal mine royalty rights from Linc for $145 million Full Article